Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Total Liabilities (2020 - 2025)

Historic Total Liabilities for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $454.5 million.

  • Cellebrite DI's Total Liabilities rose 2820.13% to $454.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $454.5 million, marking a year-over-year increase of 2820.13%. This contributed to the annual value of $454.5 million for FY2025, which is 2820.13% up from last year.
  • Latest data reveals that Cellebrite DI reported Total Liabilities of $454.5 million as of Q4 2025, which was up 2820.13% from $386.6 million recorded in Q3 2025.
  • Cellebrite DI's 5-year Total Liabilities high stood at $596.7 million for Q2 2024, and its period low was $293.0 million during Q3 2022.
  • Moreover, its 5-year median value for Total Liabilities was $382.8 million (2025), whereas its average is $402.4 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 10720.94% in 2021, then crashed by 3768.06% in 2025.
  • Quarter analysis of 5 years shows Cellebrite DI's Total Liabilities stood at $413.1 million in 2021, then fell by 20.26% to $329.4 million in 2022, then surged by 51.38% to $498.7 million in 2023, then dropped by 28.9% to $354.5 million in 2024, then increased by 28.2% to $454.5 million in 2025.
  • Its Total Liabilities was $454.5 million in Q4 2025, compared to $386.6 million in Q3 2025 and $379.0 million in Q2 2025.